Stryker Q2 net sales $4.3B (+55% YoY), raises FY2021 guidance

STRYKER CORP

2021-Q2 EPS reported $2.34 revenue$8,247,000,000

Reported net sales $4.3B, +55.4% from 2020 and +17.6% from 2019; organic net sales +42.9% from 2020.
Reported EPS $1.55; adjusted EPS $2.25 (up from $0.64 in Q2 2020).
Adjusted operating income margin 25.9% vs reported 17.0%.
Orthopaedics $1.6B (+82.3%), MedSurg $1.7B (+32.3%), Neuro/Spine $0.9B (+66.9%) from 2020.
Raises FY2021 outlook: organic net sales growth 9-10% from 2019; adj. EPS $9.25-$9.40.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.